Clinical Trial Update: Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cyclosporine for treating low blood counts caused by hematologic cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Leukemia
• Neutropenia
• Thrombocytopenia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Anemia, Leukemia | Phase 2 | Status: COMPLETED